Seeking Alpha

John Putnam » Articles » MRK |

More on MRK by John Putnam
Articles by Ticker

Latest Comments on John Putnam's Articles

  1. carrierwave on Plavix: Winners and Losers: Most medicines nowadays are taken from cures found IN HERBAL... more »
  2. Douglas Cress on Endologix: Financially Strong, Large and Growing Market: Agreed! Love this company. Loved it more at $1.25. more »
  3. Dr.Nicky on Plavix: Winners and Losers: Autogenomics is the only company in molecular diagnostics that... more »
  4. HealthcareIT on An Increase in Healthcare M&A Doesn't Yet Signal a Bottom: MedLink is public (MLKNA.OB) more »
  5. HealthcareIT on An Increase in Healthcare M&A Doesn't Yet Signal a Bottom: In reading your article you do not discuss the M&A activity in the... more »
  6. SumoBackup on An Increase in Healthcare M&A Doesn't Yet Signal a Bottom: No matter how poor people get, they'll still pay good money for... more »
  7. Cynthia on Medtronic: Slipping Off Its Perch?: Speaking of Medronic, I just read another article about a... more »
  8. Cynthia on Medtronic: Slipping Off Its Perch?: I just read another article about how the North American Spinal... more »
  9. pdriscoll on Abbott Labs and Johnson & Johnson: Clash of the Titans: Good, sanguine comparison between these two "titans". Thanks! more »
  10. Socialism cannot compete! on Medtronic: Slipping Off Its Perch?: "Since Medtronic’s stock hit its 2008 high on August 22nd of... more »
  11. Hamburger on Plavix: Winners and Losers: Give me a break Lin, herbal medicine or natural medicine is for... more »
  12. otbricki on Plavix: Winners and Losers: Nattokinase has been implicated in cerebral hemorrhages. I would... more »
  13. Lin on Plavix: Winners and Losers: Re Plavix A much better natural alternative is a substance... more »
  14. pdriscoll on 2009 Outlook for Medical Device Stocks: Perhaps the most salient impacts of the current financial... more »
  15. Anthony Alfidi on 2009 Outlook for Medical Device Stocks: Don't forget the huge premium that Eli Lilly paid for Imclone last... more »